Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies - PubMed (original) (raw)
Comparative Study
. 1985 Aug;109(8):716-21.
- PMID: 3893381
Comparative Study
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies
K S McCarty Jr et al. Arch Pathol Lab Med. 1985 Aug.
Abstract
Attempts at histochemical localization of estrogen receptor with anti-steroid antibody or some fluoresceinated estrogens have given unacceptable sensitivities and specificities when compared with biochemical methods or clinical response. In the present study a monoclonal antibody against estrogen receptor (H222 Sp gamma) was used on cryostat sections of freshly frozen breast tumors with a peroxidase-antiperoxidase immunoperoxidase technique. Biochemical receptor analyses were by dextran-coated charcoal analyses. Tumors from three separate cohorts of patients were studied as follows: population A, 62 primary breast cancers from 1983; population B, 72 primary lesions stored from 1976 to 1983; and population C, 23 patients with metastases, treated with hormonal therapy. Distinct staining was seen in the cell nucleus. A semiquantitative relationship was seen between histochemical score assessment of staining and biochemical assay in each cohort. The sensitivity and specificity using a threshold of 75 for the histochemical score and more than 20 femtomoles/mg of protein for dextran-coated charcoal analyses were as follows: population A, specificity, 89%, and sensitivity, 95%; population B, specificity, 94%, and sensitivity 88%; and for population C, the comparison was with objective clinical response yielding specificity, 89%, and sensitivity, 93%.
Similar articles
- Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT, et al. McCarty KS Jr, et al. Cancer Res. 1986 Aug;46(8 Suppl):4244s-4248s. Cancer Res. 1986. PMID: 3524805 - Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.
Shimada A, Kimura S, Abe K, Nagasaki K, Adachi I, Yamaguchi K, Suzuki M, Nakajima T, Miller LS. Shimada A, et al. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4803-7. doi: 10.1073/pnas.82.14.4803. Proc Natl Acad Sci U S A. 1985. PMID: 3860824 Free PMC article. - Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J. Andersen J. Acta Oncol. 1992;31(6):611-27. doi: 10.3109/02841869209083843. Acta Oncol. 1992. PMID: 1281648 Review. - Present status of estrogen-receptor immunohistochemistry.
van Bogaert LJ. van Bogaert LJ. Acta Histochem. 1985;76(1):29-35. doi: 10.1016/S0065-1281(85)80030-1. Acta Histochem. 1985. PMID: 2409727 Review.
Cited by
- Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL.
Sanchez J, Claus C, McIntyre C, Tanos T, Boehnke A, Friberg LE, Jönsson S, Frances N. Sanchez J, et al. Front Pharmacol. 2024 Oct 9;15:1472662. doi: 10.3389/fphar.2024.1472662. eCollection 2024. Front Pharmacol. 2024. PMID: 39444607 Free PMC article. - PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers.
Teramoto Y, Yang Z, Matsukawa T, Najafi MAE, Goto T, Miyamoto H. Teramoto Y, et al. Am J Cancer Res. 2024 Sep 15;14(9):4367-4377. doi: 10.62347/QWZY6886. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417173 Free PMC article. - Genome-wide RNA-Seq identifies TP53-mediated embryonic stem cells inhibiting tumor invasion and metastasis.
Li Y, Fan Y, Xie Y, Li L, Li J, Liu J, Jin Z, Xue H, Wang Z. Li Y, et al. Stem Cell Res Ther. 2024 Oct 16;15(1):369. doi: 10.1186/s13287-024-04000-y. Stem Cell Res Ther. 2024. PMID: 39415294 Free PMC article. - An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1.
Hagiyama M, Yoneshige A, Otani T, Wada A, Takeuchi F, Shoya Y, Inoue T, Ito A. Hagiyama M, et al. Mol Cell Oncol. 2024 Sep 5;11(1):2399379. doi: 10.1080/23723556.2024.2399379. eCollection 2024. Mol Cell Oncol. 2024. PMID: 39252827 Free PMC article. - G protein-coupled estrogen receptor 1 and collagen XVII endodomain expression in human cutaneous melanomas: can they serve as prognostic factors?
Çakır U, Balogh P, Ferenczik A, Brodszky V, Krenács T, Kárpáti S, Sárdy M, Holló P, Fábián M. Çakır U, et al. Pathol Oncol Res. 2024 Aug 26;30:1611809. doi: 10.3389/pore.2024.1611809. eCollection 2024. Pathol Oncol Res. 2024. PMID: 39252786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical